Our Fisher Clinical ServicesSM offerings are now part of the Patheon brand portfolio by Thermo Fisher Scientific. Please update your bookmark.
Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product
This poster discusses a stepwise Quality-by-Design (QbD) approach consistent with ICH Q8 (R2) and associated regulatory guidelines to build quality into a Novel ALS drug product.